Olivier Burgy

1.4k total citations
20 papers, 962 citations indexed

About

Olivier Burgy is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Olivier Burgy has authored 20 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Olivier Burgy's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13 papers), Pulmonary Hypertension Research and Treatments (6 papers) and Heat shock proteins research (4 papers). Olivier Burgy is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13 papers), Pulmonary Hypertension Research and Treatments (6 papers) and Heat shock proteins research (4 papers). Olivier Burgy collaborates with scholars based in France, United States and Canada. Olivier Burgy's co-authors include Mélanie Königshoff, Philippe Bonniaud, Pierre‐Simon Bellaye, Carmen Garrido, Christina Coughlan, Sébastien Causse, Martin Kolb, Josselyn E. Garcia‐Perez, Kimberley D. Bruce and Brianne M. Bettcher and has published in prestigious journals such as Journal of Clinical Investigation, American Journal of Respiratory and Critical Care Medicine and The FASEB Journal.

In The Last Decade

Olivier Burgy

20 papers receiving 954 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olivier Burgy France 14 560 365 165 89 88 20 962
Jeremy Herrera United States 16 407 0.7× 534 1.5× 136 0.8× 166 1.9× 99 1.1× 29 1.2k
Iliana Herrera Mexico 11 278 0.5× 530 1.5× 97 0.6× 62 0.7× 99 1.1× 24 904
Xiaojun Yang China 9 446 0.8× 184 0.5× 229 1.4× 87 1.0× 43 0.5× 24 775
Patricia Brown‐Augsburger United States 14 301 0.5× 186 0.5× 90 0.5× 91 1.0× 129 1.5× 24 904
Tsukasa Kadota Japan 16 828 1.5× 449 1.2× 423 2.6× 79 0.9× 130 1.5× 26 1.2k
Craig E. Higgins United States 19 522 0.9× 139 0.4× 313 1.9× 79 0.9× 104 1.2× 26 1.1k
Mauricio Rojas United States 17 341 0.6× 780 2.1× 142 0.9× 153 1.7× 230 2.6× 34 1.3k
José Manuel Somoza Martín Spain 20 431 0.8× 234 0.6× 111 0.7× 187 2.1× 31 0.4× 63 1.4k
Yuka Kitamura Japan 17 324 0.6× 224 0.6× 147 0.9× 70 0.8× 85 1.0× 62 862
Mojtaba Abdul Roda United States 10 348 0.6× 256 0.7× 167 1.0× 80 0.9× 211 2.4× 13 777

Countries citing papers authored by Olivier Burgy

Since Specialization
Citations

This map shows the geographic impact of Olivier Burgy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Burgy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Burgy more than expected).

Fields of papers citing papers by Olivier Burgy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Burgy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Burgy. The network helps show where Olivier Burgy may publish in the future.

Co-authorship network of co-authors of Olivier Burgy

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Burgy. A scholar is included among the top collaborators of Olivier Burgy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Burgy. Olivier Burgy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burgy, Olivier, Mathieu Moreau, Victor Gonçalves, et al.. (2025). Collagen-targeted PET imaging for progressive experimental lung fibrosis quantification and monitoring of efficacy of anti-fibrotic therapies. Theranostics. 15(6). 2092–2103. 3 indexed citations
2.
Burgy, Olivier & Mélanie Königshoff. (2024). Teatime: epigallocatechin gallate targets fibroblast–epithelial cell crosstalk to combat lung fibrosis. Journal of Clinical Investigation. 134(18). 2 indexed citations
3.
Burgy, Olivier, Lucile Dondaine, Guillaume Beltramo, et al.. (2023). HSPB5 Inhibition by NCI-41356 Reduces Experimental Lung Fibrosis by Blocking TGF-β1 Signaling. Pharmaceuticals. 16(2). 177–177. 3 indexed citations
4.
Burgy, Olivier, et al.. (2022). Extracellular Lipids in the Lung and Their Role in Pulmonary Fibrosis. Cells. 11(7). 1209–1209. 24 indexed citations
5.
Ghione, S, Randa Sghaier, Olivier Burgy, et al.. (2021). Nitric Oxide-Releasing Drug Glyceryl Trinitrate Targets JAK2/STAT3 Signaling, Migration and Invasion of Triple-Negative Breast Cancer Cells. International Journal of Molecular Sciences. 22(16). 8449–8449. 16 indexed citations
6.
Burgy, Olivier, Guillaume Beltramo, Pierre‐Simon Bellaye, et al.. (2020). TRIM33 prevents pulmonary fibrosis by impairing TGF-β1 signalling. European Respiratory Journal. 55(6). 1901346–1901346. 69 indexed citations
7.
Burgy, Olivier, Pierre‐Simon Bellaye, Guillaume Beltramo, Françoise Goirand, & Philippe Bonniaud. (2020). Pathogenesis of fibrosis in interstitial lung disease. Current Opinion in Pulmonary Medicine. 26(5). 429–435. 6 indexed citations
8.
Bellaye, Pierre‐Simon, Olivier Burgy, Philippe Bonniaud, & Martin Kolb. (2020). HSP47: a potential target for fibrotic diseases and implications for therapy. Expert Opinion on Therapeutic Targets. 25(1). 49–62. 44 indexed citations
9.
Coughlan, Christina, Kimberley D. Bruce, Olivier Burgy, et al.. (2020). Exosome Isolation by Ultracentrifugation and Precipitation and Techniques for Downstream Analyses. Current Protocols in Cell Biology. 88(1). e110–e110. 221 indexed citations
10.
Parimon, Tanyalak, Changfu Yao, David M. Habiel, et al.. (2019). Syndecan-1 promotes lung fibrosis by regulating epithelial reprogramming through extracellular vesicles. JCI Insight. 4(17). 69 indexed citations
11.
Janssens, Thomas, Olivier Burgy, Sara Rolandsson Enes, & Jana De Brandt. (2019). In the spotlight: first ERS Early Career Member Award winner, the ERS Lung Science Conference 2020 and new ECMC members. Breathe. 15(4). 330–336. 3 indexed citations
12.
Lehmann, Mareike, Olivier Burgy, Sarah Hermann, et al.. (2018). Increased Extracellular Vesicles Mediate WNT5A Signaling in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 198(12). 1527–1538. 140 indexed citations
13.
Burgy, Olivier & Mélanie Königshoff. (2018). The WNT signaling pathways in wound healing and fibrosis. Matrix Biology. 68-69. 67–80. 147 indexed citations
14.
Burgy, Olivier, et al.. (2018). Extracellular vesicles from broncho-alveolar lavage act on cellular behavior during lung fibrosis.. OA5352–OA5352. 2 indexed citations
15.
Burgy, Olivier, et al.. (2017). Cell‐specific expression of runt‐related transcription factor 2 contributes to pulmonary fibrosis. The FASEB Journal. 32(2). 703–716. 30 indexed citations
16.
Burgy, Olivier, Pierre‐Simon Bellaye, Sébastien Causse, et al.. (2016). Pleural inhibition of the caspase-1/IL-1β pathway diminishes profibrotic lung toxicity of bleomycin. Respiratory Research. 17(1). 162–162. 14 indexed citations
17.
Burgy, Olivier, Guillaume Wettstein, Pierre‐Simon Bellaye, et al.. (2016). Deglycosylated bleomycin has the antitumor activity of bleomycin without pulmonary toxicity. Science Translational Medicine. 8(326). 326ra20–326ra20. 29 indexed citations
18.
Bellaye, Pierre‐Simon, Olivier Burgy, Julien Colas, et al.. (2014). Antifibrotic Role of αB-Crystallin Inhibition in Pleural and Subpleural Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 52(2). 244–252. 18 indexed citations
19.
Bellaye, Pierre‐Simon, Olivier Burgy, Sébastien Causse, Carmen Garrido, & Philippe Bonniaud. (2014). Heat shock proteins in fibrosis and wound healing: Good or evil?. Pharmacology & Therapeutics. 143(2). 119–132. 76 indexed citations
20.
Bellaye, Pierre‐Simon, Guillaume Wettstein, Olivier Burgy, et al.. (2013). The small heat‐shock protein αB‐crystallin is essential for the nuclear localization of Smad4: impact on pulmonary fibrosis. The Journal of Pathology. 232(4). 458–472. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeremy Herrera Breakdown of academic impact, for papers by Iliana Herrera Breakdown of academic impact, for papers by Xiaojun Yang Breakdown of academic impact, for papers by Patricia Brown‐Augsburger Breakdown of academic impact, for papers by Tsukasa Kadota Breakdown of academic impact, for papers by Craig E. Higgins Breakdown of academic impact, for papers by Mauricio Rojas Breakdown of academic impact, for papers by José Manuel Somoza Martín Breakdown of academic impact, for papers by Yuka Kitamura Breakdown of academic impact, for papers by Mojtaba Abdul Roda
Rankless by CCL
2026